| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.3 | 0.07 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.29 | 0.07 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |